IBDEI1MD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27477,1,4,0)
 ;;=4^N00.0
 ;;^UTILITY(U,$J,358.3,27477,2)
 ;;=^5015491
 ;;^UTILITY(U,$J,358.3,27478,0)
 ;;=N00.1^^106^1363^7
 ;;^UTILITY(U,$J,358.3,27478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27478,1,3,0)
 ;;=3^Acute nephritic syndrome w/ focal and segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,27478,1,4,0)
 ;;=4^N00.1
 ;;^UTILITY(U,$J,358.3,27478,2)
 ;;=^5015492
 ;;^UTILITY(U,$J,358.3,27479,0)
 ;;=N00.2^^106^1363^4
 ;;^UTILITY(U,$J,358.3,27479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27479,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,27479,1,4,0)
 ;;=4^N00.2
 ;;^UTILITY(U,$J,358.3,27479,2)
 ;;=^5015493
 ;;^UTILITY(U,$J,358.3,27480,0)
 ;;=N00.3^^106^1363^5
 ;;^UTILITY(U,$J,358.3,27480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27480,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,27480,1,4,0)
 ;;=4^N00.3
 ;;^UTILITY(U,$J,358.3,27480,2)
 ;;=^5015494
 ;;^UTILITY(U,$J,358.3,27481,0)
 ;;=N00.4^^106^1363^3
 ;;^UTILITY(U,$J,358.3,27481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27481,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,27481,1,4,0)
 ;;=4^N00.4
 ;;^UTILITY(U,$J,358.3,27481,2)
 ;;=^5015495
 ;;^UTILITY(U,$J,358.3,27482,0)
 ;;=N00.5^^106^1363^6
 ;;^UTILITY(U,$J,358.3,27482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27482,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,27482,1,4,0)
 ;;=4^N00.5
 ;;^UTILITY(U,$J,358.3,27482,2)
 ;;=^5015496
 ;;^UTILITY(U,$J,358.3,27483,0)
 ;;=N00.6^^106^1363^1
 ;;^UTILITY(U,$J,358.3,27483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27483,1,3,0)
 ;;=3^Acute nephritic syndrome w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,27483,1,4,0)
 ;;=4^N00.6
 ;;^UTILITY(U,$J,358.3,27483,2)
 ;;=^5015497
 ;;^UTILITY(U,$J,358.3,27484,0)
 ;;=N00.7^^106^1363^2
 ;;^UTILITY(U,$J,358.3,27484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27484,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,27484,1,4,0)
 ;;=4^N00.7
 ;;^UTILITY(U,$J,358.3,27484,2)
 ;;=^5015498
 ;;^UTILITY(U,$J,358.3,27485,0)
 ;;=N00.8^^106^1363^9
 ;;^UTILITY(U,$J,358.3,27485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27485,1,3,0)
 ;;=3^Acute nephritic syndrome w/ other morphologic changes
 ;;^UTILITY(U,$J,358.3,27485,1,4,0)
 ;;=4^N00.8
 ;;^UTILITY(U,$J,358.3,27485,2)
 ;;=^5015499
 ;;^UTILITY(U,$J,358.3,27486,0)
 ;;=N00.9^^106^1363^10
 ;;^UTILITY(U,$J,358.3,27486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27486,1,3,0)
 ;;=3^Acute nephritic syndrome w/ unsp morphologic changes
 ;;^UTILITY(U,$J,358.3,27486,1,4,0)
 ;;=4^N00.9
 ;;^UTILITY(U,$J,358.3,27486,2)
 ;;=^5015500
 ;;^UTILITY(U,$J,358.3,27487,0)
 ;;=N01.0^^106^1363^70
 ;;^UTILITY(U,$J,358.3,27487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27487,1,3,0)
 ;;=3^Rapidly progr neph synd w/ minor glomerular abnlt
 ;;^UTILITY(U,$J,358.3,27487,1,4,0)
 ;;=4^N01.0
 ;;^UTILITY(U,$J,358.3,27487,2)
 ;;=^5015501
 ;;^UTILITY(U,$J,358.3,27488,0)
 ;;=N01.1^^106^1363^69
 ;;^UTILITY(U,$J,358.3,27488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27488,1,3,0)
 ;;=3^Rapidly progr neph synd w/ focal & seg glomerular lesions
 ;;^UTILITY(U,$J,358.3,27488,1,4,0)
 ;;=4^N01.1
 ;;^UTILITY(U,$J,358.3,27488,2)
 ;;=^5015502
 ;;^UTILITY(U,$J,358.3,27489,0)
 ;;=N01.2^^106^1363^67
 ;;^UTILITY(U,$J,358.3,27489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27489,1,3,0)
 ;;=3^Rapidly progr neph synd w/ diffuse membranous glomrlneph
